593 Results

People

  1. Old
    Old
  2. Ritter
    Ritter
  3. Jungbluth
    Jungbluth
  4. Gnjatic
    Gnjatic
  5. Chen
    Chen
  6. Stockert
    Stockert
  7. Oettgen
    Oettgen
  8. Welt
    Welt
  9. Rettig
    Rettig
  10. Lloyd
    Lloyd

Groups

  1. Sloan Kettering Institute Postdocs (129)
  2. Department of Pathology and Laboratory Medicine (121)
  3. Sloan Kettering Institute Faculty (82)
  4. Department of Medicine (69)
  5. GSK Faculty (67)
  6. Molecular Pharmacology and Chemistry Program Faculty (57)
  7. Solid Tumor Oncology Division (54)
  8. Melanoma Disease Management Team (46)
  9. Molecular Imaging and Therapy Service (42)
  10. Radiology, Department of (42)
  1. "Lloyd Old"
Formats
  1. Journal Article (459)
  2. Meeting Abstract (127)
  3. Conference Paper (6)
  4. Book Section (1)
Groups
  1. Sloan Kettering Institute Postdocs (129)
  2. Department of Pathology and Laboratory Medicine (121)
  3. Sloan Kettering Institute Faculty (82)
  4. Department of Medicine (69)
  5. GSK Faculty (67)
  6. Molecular Pharmacology and Chemistry Program Faculty (57)

More Groups

People
  1. Lloyd Old (593)
  2. Gerd Ritter (127)
  3. Achim Jungbluth (115)
  4. Sacha Gnjatic (87)
  5. Yao-Tseng Chen (80)
  6. Elisabeth Stockert (78)

More People

Years
  1. 2022 (1)
  2. 2018 (1)
  3. 2015 (2)
  4. 2014 (1)
  5. 2013 (9)
  6. 2012 (18)

More Years

Publications
  1. Proceedings of the National Academy of Sciences of the United States of America (74)
  2. Cancer Research (44)
  3. Cancer Immunity (40)
  4. International Journal of Cancer (35)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (29)
  6. Journal of Clinical Oncology (24)

More Publications

Publishers
  1. American Association for Cancer Research (98)
  2. National Academy of Sciences (74)
  3. Nature Publishing Group (42)
  4. John Wiley & Sons (41)
  5. Academy of Cancer Immunology (40)
  6. Elsevier Science, Inc. (26)

More Publishers

Results (593)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Systems-level mapping of cancer testis antigen 1b/a to sarcoma pathways identifies activated ran binding-2 E3 SUMO-protein ligase and transducin-like enhancer protein 1
    Journal Article

    Papanikolaou, N. A.; Hytiroglou, P.; Pantelidou, P.; Papavassiliou, A. G.; Old, L. L.
    Frontiers in Genetics (2022)

    Fulltext@MSK | Save
  • IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001. 410: 1107-1111
    Journal Article

    Shankaran, V.; Ikeda, H.; Bruce, A. T.; White, J. M.; Swanson, P. E.; Old, L. J.; Schreiber, R. D.
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • Direct tumor recognition by a human CD4+ T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses
    Journal Article

    Matsuzaki, J.; Tsuji, T.; Luescher, I. F.; Shiku, H.; Mineno, J.; Okamoto, S.; Old, L. J.; Shrikant, P.; Gnjatic, S.; Odunsi, K.
    Scientific Reports (2015)

    Fulltext@MSK | Save
  • PET-based compartmental modeling of (124)I-A33 antibody: Quantitative characterization of patient-specific tumor targeting in colorectal cancer
    Journal Article

    Zanzonico, P.; Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Smith-Jones, P.; Ruan, S.; Divgi, C.; Scott, A. M.; Kemeny, N. E.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2015)

    Fulltext@MSK | Save
  • Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells
    Journal Article

    Matsuzaki, J.; Tsuji, T.; Luescher, I.; Old, L. J.; Shrikant, P.; Gnjatic, S.; Odunsi, K.
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein
    Journal Article

    Reis, B. S.; Jungbluth, A. A.; Frosina, D.; Holz, M.; Ritter, E.; Nakayama, E.; Ishida, T.; Obata, Y.; Carver, B.; Scher, H.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Process development and production of cGMP grade Melan-A for cancer vaccine clinical trials
    Journal Article

    Bardliving, C. L.; Lowe, A. J.; Huang, C. J.; Manley, L.; Ritter, G.; Old, L.; Batt, C. A.
    Protein Expression and Purification (2013)

    Fulltext@MSK | Save
  • Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: A novel reagent for targeted antibody therapy of cancer
    Journal Article

    dos Santos, M. L.; Yeda, F. P.; Tsuruta, L. R.; Horta, B. B.; Pimenta, A. A. Jr; Degaki, T. L.; Soares, I. C.; Tuma, M. C.; Okamoto, O. K.; Alves, V. A. F.; more...
    PLoS ONE (2013)

    Fulltext@MSK | Save
  • NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma
    Journal Article

    Von Boehmer, L.; Mattle, M.; Bode, P.; Landshammer, A.; Schäfer, C.; Nuber, N.; Ritter, G.; Old, L.; Moch, H.; Schäfer, N.; more...
    Cancer Immunity (2013)

    Fulltext@MSK | Save
  • Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
    Journal Article

    Ott, P. A.; Carvajal, R. D.; Pandit-Taskar, N.; Jungbluth, A. A.; Hoffman, E. W.; Wu, B. W.; Bomalaski, J. S.; Venhaus, R.; Pan, L.; Old, L. J.; more...
    Investigational New Drugs (2013)

    Fulltext@MSK | Save